Back Park, A (15 March 2024) 'GLP-1s on track to take drug sales throne from PD-1 inhibitors in 2024', Fierce Pharma
The sample sizes for both in vitro transfection studies (Hepa1-6 and HepG2 cells) and in vivo studies (Balb/c and DIO mice) were predetermined
So, what's the deal with GIP, you might ask
Long-Term Health Considerations For some individuals, especially those with obesity-related health conditions (like type 2 diabetes, high blood pressure, or cardiovascular issues), staying on GLP-1 medications for the long term might be necessary to manage overall health, not just weight loss
There are no wide scale studies available to show how effective these patches are, but either due to the placebo effect, actual effectiveness of the ingredients, or biased economically motivated reasons, some people swear by them